Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $19.1 million.

  • Arcutis Biotherapeutics' Other Operating Expenses rose 57.82% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 120.55%. This contributed to the annual value of $19.1 million for FY2024, which is 283.56% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Other Operating Expenses stood at $19.1 million for FY2024, which was up 283.56% from $5.0 million recorded in FY2023.
  • Arcutis Biotherapeutics' Other Operating Expenses' 5-year high stood at $19.1 million during FY2024, with a 5-year trough of $754,000 in FY2022.
  • Its 3-year average for Other Operating Expenses is $8.3 million, with a median of $5.0 million in 2023.
  • Data for Arcutis Biotherapeutics' Other Operating Expenses shows a peak YoY skyrocketed of 561.41% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Arcutis Biotherapeutics' Other Operating Expenses stood at $754,000 in 2022, then skyrocketed by 561.41% to $5.0 million in 2023, then skyrocketed by 283.56% to $19.1 million in 2024.